Summary
Chinese hamster (CHO) ovary cells are the production host for a +50 billion €/yr biopharmaceuticals market. Current CHO production platforms dates to 1980 and are based primarily on media and process optimisation with little consideration to the optimization of the cellular machinery. Fortunately, with the recent sequencing of the CHO genome, an opportunity has opened to significantly advance the CHO platform. The benefit will be advanced production flexibility and a lower production cost.
This ITN graduate training programme - eCHO Systems - will blend conventional molecular, cellular, and synthetic biology with genome scale systems biology training in ‘omics data acquisition, biological network modeling, and genome engineering in three interdisciplinary topics:
1) Acquisition of large scale ‘omics data sets and their incorporation into genome-scale mathematical models
2) Development of genome engineering tools, enabling synthetic biology
3) Application of systems and synthetic biology and genome engineering to improve performance of CHO producers
The training projects are supported by 15 industrial participants, which will participate in the research and test the results. ESR training will include intense courses focused on computational systems biology, cell biology, business and entrepreneurship. The three universities bring unique complementary skills in systems and synthetic biology, ‘omics technologies, cytometry, and molecular cell biology which will provide depth and breadth to this training. The eCHO Systems will produce four major outputs: General knowledge to improve the productivity, quality, and efficiency of CHO platform cell lines, new systems models for CHO cells, new CHO cell line chassises generated through synthetic biology approaches, high quality education at the graduate level, and a cadre of interdisciplinary graduates poised to transform biopharmaceutical biotechnology.
This ITN graduate training programme - eCHO Systems - will blend conventional molecular, cellular, and synthetic biology with genome scale systems biology training in ‘omics data acquisition, biological network modeling, and genome engineering in three interdisciplinary topics:
1) Acquisition of large scale ‘omics data sets and their incorporation into genome-scale mathematical models
2) Development of genome engineering tools, enabling synthetic biology
3) Application of systems and synthetic biology and genome engineering to improve performance of CHO producers
The training projects are supported by 15 industrial participants, which will participate in the research and test the results. ESR training will include intense courses focused on computational systems biology, cell biology, business and entrepreneurship. The three universities bring unique complementary skills in systems and synthetic biology, ‘omics technologies, cytometry, and molecular cell biology which will provide depth and breadth to this training. The eCHO Systems will produce four major outputs: General knowledge to improve the productivity, quality, and efficiency of CHO platform cell lines, new systems models for CHO cells, new CHO cell line chassises generated through synthetic biology approaches, high quality education at the graduate level, and a cadre of interdisciplinary graduates poised to transform biopharmaceutical biotechnology.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/642663 |
| Start date: | 01-01-2015 |
| End date: | 31-12-2018 |
| Total budget - Public funding: | 4 044 794,43 Euro - 4 044 793,00 Euro |
Cordis data
Original description
Chinese hamster (CHO) ovary cells are the production host for a +50 billion €/yr biopharmaceuticals market. Current CHO production platforms dates to 1980 and are based primarily on media and process optimisation with little consideration to the optimization of the cellular machinery. Fortunately, with the recent sequencing of the CHO genome, an opportunity has opened to significantly advance the CHO platform. The benefit will be advanced production flexibility and a lower production cost.This ITN graduate training programme - eCHO Systems - will blend conventional molecular, cellular, and synthetic biology with genome scale systems biology training in ‘omics data acquisition, biological network modeling, and genome engineering in three interdisciplinary topics:
1) Acquisition of large scale ‘omics data sets and their incorporation into genome-scale mathematical models
2) Development of genome engineering tools, enabling synthetic biology
3) Application of systems and synthetic biology and genome engineering to improve performance of CHO producers
The training projects are supported by 15 industrial participants, which will participate in the research and test the results. ESR training will include intense courses focused on computational systems biology, cell biology, business and entrepreneurship. The three universities bring unique complementary skills in systems and synthetic biology, ‘omics technologies, cytometry, and molecular cell biology which will provide depth and breadth to this training. The eCHO Systems will produce four major outputs: General knowledge to improve the productivity, quality, and efficiency of CHO platform cell lines, new systems models for CHO cells, new CHO cell line chassises generated through synthetic biology approaches, high quality education at the graduate level, and a cadre of interdisciplinary graduates poised to transform biopharmaceutical biotechnology.
Status
CLOSEDCall topic
MSCA-ITN-2014-ETNUpdate Date
28-04-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Search
Organisations
-
| DANMARKS TEKNISKE UNIVERSITET (Coördinator)
-
| ACIB GMBH
-
| BIONEER A/S
-
| BOEHRINGER INGELHEIM PHARMA GMBH &CO KG
-
| CHORUS GMBH
-
| CMC BIOLOGICS AS
-
| Dublin City University
-
| ELI LILLY AND COMPANY LTD
-
| EVERCYTE GMBH
-
| FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED
-
| ICOSAGEN AS
-
| JANSSEN BIOLOGICS BV
-
| RENTSCHLER BIOTECHNOLOGIE GMBH
-
| Symphogen A/S
-
| UCB PHARMA SA